Newell's neuroscience company Starfish Neuroscience plans to launch its first brain chip by the end of the year.

The FDA approved Abbott's Tendyne minimally invasive heart replacement for mitral valve disease that could disqualify ...

The chips aren’t earmarked for video game applications just yet, but Valve and the wider games industry are eyeing plenty of ...

The FDA gave the OK for the North Chicago-based medical device maker's Tendyne transcatheter mitral valve replacement.

Abbott (NYSE: ABT) announced today that it received FDA approval for its Tendyne transcatheter mitral valve replacement (TMVR ...

St. Luke’s Heart Team pioneers first EVOQUE tricuspid valve replacement in the region, offering new hope for patients with ...

Valve’s founder, Gabe Newell has reportedly been investing in a brain chip company that’s currently lining up its first big release.

As Starfish Technologies approaches the launch of its first chips, the intersection of neuroscience, medicine, and technology ...

The stealthy startup thinks multiple simultaneous smaller brain implants could be better than one.

Valve has been building up to this for months, first in preview, then in beta, and now finally in a full stable release: a ...

Waiting and hoping for Half-Life 3? It may still happen, but Valve co-founder and president Gabe Newell has other things on ...

Valve’s huge new SteamOS update is finally here, and with it arrives support for the Steam Deck’s rivals, Lenovo’s Legion Go ...